Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Significance and Clinical Characteristics of Molecular Pathology and Genetic Variation in Brain Gliomas

NCT04216537 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.

NCT NCT04216537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04216537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Significance and Clinical Characteristics of Molecular Pathology and Genetic Variation in Brain Gliomas
Lead sponsor
The First Affiliated Hospital of Zhengzhou University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
June 1, 2025
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic change, glioma, molecular sequence variation